The NanoDem project is reaching its conclusion with the successful development of a prototype analyser. Partners met in Munich Nov 28 to Dec 1st for the final review meeting which involved assessment by the EC project officer. Clinical evaluations will take place during the summer 2017 on receiving ethics committee approval which is expected any day now. EC officer commended the consortium on their progress and excellent co-operations between leading academic centres and successful SMEs. As a consequent of this initial work the partners are likely to make a further EU application to support extended clinical evaluations hopeful involving sites in several European countries. The project involves therapeutic drug monitoring specifically immunosuppressant monitoring.